without compromise.
Vena Vitals joined ULP with just 2 full-time employees; today, they employ a staff of 13. Beyond tangible resources, ULP has played a key role in connecting Vena Vitals with investors, strategic partners, and suppliers. The visibility and network introductions provided by ULP have been instrumental in securing funding, with significant investments stemming directly from the ULP ecosystem.
Ray Liu, CEO of Vena Vitals, brings over 25 years of experience to the table, rooted in a deep commitment to advance medical technologies, save lives and help patients live longer, happier lives. As the CEO, Liu’s vision aligns seamlessly with the company’s goal—to make a transformative impact on cardiovascular healthcare through cutting-edge technology. Michelle Khine, a distinguished professor in Biomedical Engineering (BME) at UC Irvine, stands as a pivotal co-founder of Vena Vitals. Completing the trio of founders is Josh Kim, PhD and former post-doc student of Michelle Khine. His unique perspective, forged through academic rigor and practical experience, contributes to the multifaceted approach the team takes in tackling cardiovascular health challenges. The success of Vena Vitals is also attributed to its strategic decision to apply to become a resident at ULP. The facilities, equipment, and support infrastructure provided by ULP have allowed Vena Vitals to focus on developing both groundbreaking technology and building a skilled and dedicated team. Ray shared, “The ULP ecosystem has proven instrumental in attracting and retaining the best talent from around the country.” In December 2020,
13 University Lab Partners 2023 Annual Report | Breakthroughs Today, Careers Tomorrow
Made with FlippingBook - Online catalogs